Clinical trial
Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep…
NCT00067093 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00067093 |
|---|---|
| Title | Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | SanOrg34006, LMW heparin, Unfractionated heparin, Vitamin K antagonist (VKA) |
| Enrollment | 1,452 |
| Start date | May 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Aug 13, 2003 |
| Last update posted | Apr 6, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: